|
cont. from
Antidepressant medications are very effective; reports indicate that they are
90% successful in treating depression. In general, medications are taken for at
least 4 to 8 months to assure complete and effective treatment. However,
antidepressants often cause adverse side effects, making it difficult for some
people to comply with taking their medications. Medications must not be stopped
without first discussing this change with a physician. Most antidepressants
cause withdrawal symptoms if they are not discontinued slowly over time with
guidance from a physician.
There are several classes of antidepressant medications, including:
Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs increase the activity of a chemical in the brain called serotonin. Most
healthcare practitioners will prescribe SSRIs before any other antidepressant
medication for depression, in part because the side effects associated with
SSRIs are generally fewer than for other classes of antidepressants. Typical
side effects caused by SSRIs include stomach upset, weight gain or loss,
drowsiness, sexual dysfunction (such as impotence, decreased libido, and
diminished orgasm), headache, jaw grinding, and apathy. Very unusual side
effects from this class of prescription drugs include extreme agitation,
impulsivity, tremors, and insomnia. People who discontinue taking SSRIs due to
side effects usually attribute their discontent to sexual dysfunction.
Drugs classified as SSRIs include:
Another group of antidepressant medications (which are similar to SSRIs, but target other brain chemicals in addition to serotonin) may cause
fewer negative sexual side effects. These include:
- Bupropion
(Wellbutrin) - should not be used if there is history of or risk for seizure.
Low sexual side-effect profile.
- Nefazodone
(Serzone) - no sexual dysfunction reported; begins to work very quickly; may
cause a decrease in blood pressure when going from lying or sitting to standing
- Venlafaxine
(Effexor) - may impair sexual function; not recommended in the elderly; may
improve quality of life more effectively than other antidepressants, but can
cause irregular heart rhythm; withdrawal from the medication is difficult
- Mirtazapine - may be particularly effective if feelings of anxiety are also
present; helps with insomnia but may cause drowsiness; other side effects are
blurred vision, weight gain, and damage to production of cells in the bone
marrow (very rare)
- Maprotiline
- may cause dry mouth, drowsiness, sensitivity to
the sun, and seizures
Tricyclic Antidepressants
Tricyclics increase the activity of the brain chemicals serotonin and
norepinephrine. They are as effective as SSRIs, but are usually prescribed only
to those who do not respond well to SSRIs because side effects are quite common
and are usually less tolerable. Dry mouth, blurred vision, constipation, sexual
dysfunction, weight gain, dizziness, drowsiness, urinary urgency (a sense that
one has to urinate even when the bladder is empty), drop in blood pressure when
going from lying or sitting to standing (causes dizziness and lightheadedness),
and irregular heart rhythm are among the side effects of tricyclics.
Tricyclic antidepressants include:
- Amitriptyline
- Amoxapine - increases risk of seizure in those who are prone to
have a seizure
- Clomipramine - used for obsessive/compulsive disorder
- Desipramine
- Doxepin - may help with insomnia
- Imipramine
- may cause a rare lung disorder called
idiopathic pulmonary fibrosis
- Nortriptyline
- less risk of irregular heart rhythm
than others in this class
- Protriptyline - less drowsiness than others in this
class and may even cause weight loss; may lead to sun sensitivity
- Trimipramine - high risk for irregular heart rhythm
Monoamine Oxidase Inhibitors
(MAOIs)
MAOIs boost the levels of norepinephrine, dopamine, and serotonin in the
brain. MAOIs are generally prescribed only when other antidepressants have not
been effective, which may occur in people with atypical depression. People who
take MAOIs may experience a sharp increase in blood pressure after consuming
food or drink containing the amino acid tyramine (found in such foods as aged
cheeses and red wine). MAOIs also negatively interact with other medications,
including ritalin (used for attention deficit hyperactivity disorder) and
pseudoephedrine (decongestant in many over the counter and prescription
medications), and should not be taken with other classes of antidepressants.
MAOIs include:
- Phenelzine—should be avoided with a history of seizures or bipolar disorder
(manic-depression)
- Isocarboxazid—side effects include drowsiness, sexual
dysfunction, weakness, trembling, and blurred vision
- Tranylcypromine—should not
be used if there is any history of kidney disease or bipolar disorder
Warning
Suicidality in Children and Adolescents —
Antidepressants increased the risk of suicidal thinking and behavior (suicidality)
in short-term studies in children and adolescents with major depressive
disorder (MDD) and other psychiatric disorders. Anyone considering the
use of any antidepressant in a child or adolescent
must balance this risk with the clinical need. Patients who are started
on therapy should be observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers
should be advised of the need for close observation and communication
with the prescriber. Most antidepressants (except Prozac) are not approved for use in pediatric
patients. Pooled analyses
of short-term (4 to 16 weeks) placebo-controlled trials of 9
antidepressant drugs (SSRIs and others) in children and adolescents with
major depressive disorder (MDD), obsessive compulsive disorder (OCD), or
other psychiatric disorders (a total of 24 trials involving over 4400
patients) have revealed a greater risk of adverse events representing
suicidal thinking or behavior (suicidality) during the first few months
of treatment in those receiving antidepressants. The average risk of
such events in patients receiving antidepressants was 4%, twice the
placebo risk of 2%. No suicides occurred in these trials.
|
-
Electroconvulsive Therapy (ECT) for depression is usually reserved for cases
in which all other therapies have been unsuccessful. In this procedure, a small
electrical current induces a seizure lasting approximately 40 seconds. A muscle
relaxant and mild sedative are administered prior to the procedure. ECT is
generally repeated every 2 to 5 days for a total of six treatments. It may cause
temporary confusion, memory impairment, headache, muscle aches, irregular heart
rhythm, or nausea.
- Magnetic Resonance Imaging (MRI) - Guided Cingulotomy involves
the application of an electrical current to a specific part of the brain; the
MRI is used as a guide for an exact placement. Long-term improvement has been
reported using this technique in over 50% of people with depression who have not
responded to other modes of therapy.
continue . section table of contents
top .
pages 1 2
3 4
5 6
7 8 .
send to friend .
depression site map
Reviewed: 03/2006
|
|